Melanotan II
Melanotan II
Melanotan II is known for tanning and libido-related demand, but its regulatory profile remains unfavorable.
Current status
Restricted
Tanning and sexual-wellness interest, with current federal compounding constraints still in play.
FDA category
Category 2
Can pharmacies compound this?
No
Reclassification expected?
Unclear
The peptide remains commercially visible online without a corresponding lawful compounding path.
Primary Use
Tanning and sexual-wellness interest
Regulatory Timeline
Feb 27, 2026
Political pressure and market expectations increased around a future peptide reclassification review.
Sep 29, 2023
Current status signal recorded: No current sign of an easier federal path..
Mar 15, 2023
FDA peptide compounding scrutiny intensified across 503A and 503B channels.
Get notified...
Get notified when Melanotan II status changes
State-specific notes
Texas
Commercial demand does not translate to pharmacy access.